
Aldena Therapeutics
Developing therapies for Dermatology, discovering and enabling delivery of nucleic acid therapies in conditions with high burden to patients.
Enterprise value
$120—180m
Authorizing premium user...
Developing therapies for Dermatology, discovering and enabling delivery of nucleic acid therapies in conditions with high burden to patients.